top of page
Search
Position Review June 2025
This is the first position review I have written about. However, I want to start providing updates on positions and clinical trial...
Jul 25 min read
A Follow-up on UroGen’s PDUFA
A follow-up on UroGen's upcoming PDUFA
Jun 83 min read
UroGen Pharma – UGN-102 PDUFA June 13th
This post details the upcoming UroGen PDUFA on June 13th.
Jun 64 min read
Inmune Bio – XPro for Alzheimer’s Disease Phase 2
This article details why XPro and Inmune Bio will fail their Alzheimer's Phase 3 results.
May 177 min read
Summit Therapeutics – Ivonescimab in Non-Squamous NSCLC Clinical Trial and Beyond
Summit Therapeutics presents a buying opportunity in the long-term. Ivonescimab looks to change the cancer care landscape.
May 15 min read
Vera Therapeutics Atacicept IgAN Phase 3 Trial
Vera Therapeutics has an upcoming phase 3 topline readout for atacicept.
Apr 227 min read
Praxis FDA Clinical Trial Phase 3 - Upcoming Interim Results Q1 2025
Executive Summary - Praxis is a short going into interim results. Praxis Precision Medicines is developing Ulixacaltamide, a small...
Apr 158 min read
Roivant/Immunovant - Batoclimab Phase 3 Results
Executive Summary Immunovant will soon publish their phase 3 results for batoclimab, a monoclonal antibody developed to treat Myasthenia...
Apr 157 min read
Celcuity - Gedatolisib Phase 3 Results
Celcuity gedatolisib phase 3 analysis for breast cancer
Apr 157 min read
bottom of page